HeartSciencesHSCS -1.18%41 Days Payable is 0.00 as of Jan. 2026. GuruFocus rates HSCS with a GF Score™ of 41/100 and a GF Value™ of $2.61 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 795 Medical Devices & Instruments companies, HeartSciences ranks better than 99.5% on this metric.
The historical rank and industry rank for HeartSciences's Days Payable or its related term are showing as below:
HSCS'
s Days Payable Range Over the Past 10 Years
Min: 2848.59 Med: 28169.64 Max: 80665
Current: 31663.75
During the past 6 years, HeartSciences's highest Days Payable was 80665.00. The lowest was 2848.59. And the median was 28169.64.
HSCS's Days Payable is ranked better than 99.5% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs HSCS: 31663.75
HeartSciences's Days Payable
stayed the same
from Jan. 2025 (0.00) to Jan. 2026 (0.00).
stayed the same
HeartSciences Days Payable Related Terms
HeartSciences Days Payable Historical Data
* Premium members only.
The historical data trend for HeartSciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, HeartSciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HeartSciences Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's Days Payable distribution charts can be found below:
* The bar in red indicates where HeartSciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
HeartSciences's Days Payable for the fiscal year that ended in Apr. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HeartSciences (HSCS) has a Days Payable of 0.00 as of Jan. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HeartSciences and its competitors. Over the past decade, HeartSciences' Days Payable has ranged from 2,848.59 to 80,665.00. According to the industry distribution chart, HeartSciences ranks #4 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 0.5%.
Is HeartSciences' Days Payable too high?
HeartSciences' current Days Payable is 0.00. Over the past 10 years, this metric has ranged from a low of 2,848.59 to a high of 80,665.00. Based on the distribution chart, HeartSciences ranks #4 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, HeartSciences has a GF Score™ of 41/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Days Payable compare to FEED and ITOC?
According to the Medical Devices & Instruments industry distribution chart, HeartSciences ranks #4 out of 795 companies for Days Payable. This places HeartSciences in the top 1% of its industry — outperforming the majority of peers. The industry median Days Payable is 67.87. Historically, HeartSciences' own Days Payable has ranged from 2,848.59 to 80,665.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on HeartSciences and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HeartSciences's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.61, compared to a current price of $2.90 — trading 11.1% above its estimated fair value. The current Days Payable is 0.00. HeartSciences' overall GF Score™ is 41/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For HeartSciences (HSCS), the current Days Payable is 0.00 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HeartSciences (HSCS) Overvalued in 2026?
Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued.
The current stock price of $2.90 is trading 11.1% above its estimated GF Value™ of $2.61.
GuruFocus considers HeartSciences to be Modestly Overvalued.
Key valuation signals for HSCS:
Days Payable: 0.00
GF Value™: $2.61 vs. price of $2.90 (11.1% above fair value)
No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
41GF Score
Get the complete analysis for HSCS
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSCS has been successfully added to your 
